The South Bend Symphony Orchestra will present a Masterworks concert at the Morris Performing Arts Center. The program Jessica Carter's Hidden: In memory of Rosemary Sanders, Max Bruch's Violin ...

When composer and conductor Steve Hackman stepped on stage at Chicago’s Harris theatre, he might as well have been walking ...

That Beethoven was enduring frustrations of going deaf, unrequited love and strife with patrons when he composed his Piano Sonata No. 23 might explain its dark and agitated feel throughout, until all ...

An illustration Anthropic commissioned to mark the release of Opus 4.5. (Anthropic) Hot on the heels of Google's Gemini 3 Pro release, Anthropic has announced an update for its flagship Opus model.

George Frederick Bristow, born 200 years ago this month, struggled to find American champions of his music as orchestras ...

LA JOLLA, California–The Jewish Community Symphony, formerly the Tifereth Israel Community Orchestra (TICO), now rebranded in ...

Anthropic today announced the launch of Claude Opus 4.5, which it says is the "best model in the world for coding, agents, and computer use." It's improved over prior models for everyday tasks like ...

Of course, Opus 4.5 does a lot more than coding. Anthropic says it is also the “best model in the world” for powering AI agents and for operating a computer, and that it’s meaningfully better than ...

On Monday, Anthropic announced Opus 4.5, the latest version of its flagship model. It’s the last of Anthropic’s 4.5 series of models to be released, following the launch of Sonnet 4.5 in September and ...

Anthropic released its most capable artificial intelligence model yet on Monday, slashing prices by roughly two-thirds while claiming state-of-the-art performance on software engineering tasks — a ...

Anthropic's new AI model, Claude Opus 4.5, has arrived. The model reportedly excels at creative problem-solving. It also excels at agentic tasks, according to Anthropic. AI startup Anthropic released ...

RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene ...